PALI

Palisade Bio, Inc. PALI

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PALI ASBP CRIS ENTO PCSA BCTX HOTH LPTX CTXR DARE
6M 203.16 % -59.52 % -51.61 % 89.21 % -46.58 % -72.39 % -12.61 % 314.45 % -33.28 % -17.80 %
YTD 18.28 % -99.16 % -75.24 % 35.57 % -84.41 % -90.70 % 35.05 % -63.66 % -79.37 % -32.61 %
1Y 24.29 % -99.16 % -66.56 % 39.15 % -85.33 % -89.93 % 36.84 % -60.74 % -75.81 % -34.24 %
3Y -91.85 % -99.16 % -88.83 % -98.74 % -99.40 % -98.74 % -66.12 % -72.98 % -96.02 % -78.47 %
5Y -99.94 % -99.16 % -99.33 % -100.00 % -99.90 % -98.68 % -97.48 % -94.71 % -97.01 % -86.20 %
10Y -100.00 % -99.16 % -99.63 % -100.00 % -99.56 % 5 226.92 % -99.51 % -98.51 % -99.88 % -99.50 %
From the beginning -100.00 % -99.16 % -99.96 % -100.00 % -99.96 % 1 644.55 % -99.51 % -98.51 % -99.79 % -99.74 %

Dividend